Oxygen Biotherapeutics, Inc., (Nasdaq: OXBT) announced it has signed a Definitive Agreement (“Agreement”) to acquire certain assets of Phyxius Pharma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE